KCNJ11 and diabetes mellitus: The low BMI of this patient also supports this argument.In conclusion, molecular genetic diagnosis is recommended in all patients with PNDM since the identification of Kir6.2 or SUR1 mutations allows a successful change to SU therapy that leads to dramatic improvement in diabetes control and quality of life.